Results 231 to 240 of about 129,195 (289)

Serum Proteomic Analysis Using Gel‐Based Liquid Chromatography Tandem Mass Spectrometry Reveals Differences Between Canine Oral Malignancies and Non‐Malignant Conditions

Veterinary Medicine and Science, Volume 12, Issue 3, May 2026.
This study establishes a GeLC‐MS/MS‐based serum proteomics workflow for canine oral oncology to differentiate malignancies from non‐malignant conditions. Comprehensive protein profiling, pathway analysis and protein–drug interaction mapping reveal candidate biomarkers and insights into the pathogenesis of canine oral cancers.
Sekkarin Ploypetch, Sittiruk Roytrakul, Janthima Jaresitthikunchai, Narumon Phaonakrop, Gunnaporn Suriyaphol   +4 more
wiley   +1 more source

Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center. [PDF]

Front Oncol
Schwörer I, Huwer S, Rautenberg B, Neubauer J, Juhasz-Böss I, Jung L.   +5 more
europepmc   +1 more source

Atypical metastatic osteosarcoma pattern in a dog: Lymphatic, neurovascular and subcutaneous metastasis

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 6‐year‐old, spayed, female labrador retriever was presented with left distal radial swelling. Imaging, cytology and biopsy identified an aggressive radial lesion with metastasis to the left axillary lymph node, and a diagnosis of presumptive osteosarcoma was made.
Veronica Perez‐Rodriguez, Laura Venner, Rowan Milner, Jishnu Rao Gutti, Elizabeth A. Maxwell   +4 more
wiley   +1 more source

Obesity and Tolerance to Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Cohort Study. [PDF]

Cancers (Basel)
Machado MS, Santos MP, Relvas C, Pereira MQ, Sousa M, Santos E, Pereira BA, Parreira J, Esteves S, Ravasco P, Vaz F, Nunes H.   +11 more
europepmc   +1 more source

Evaluating chemotherapy-driven placental alterations and their impact on fetal development. [PDF]

Front Toxicol
De Clercq K, Velazquez C, Persoons E, Wolters V, Van de Ven M, Amant F.   +5 more
europepmc   +1 more source

Updating the Role of Carboplatin Added to Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis. [PDF]

Cancers (Basel)
Taglialatela I, Ruffilli B, Conte B, D'Avanzo F, Rossi V, Nardin S, Gennari A.   +6 more
europepmc   +1 more source

Platinum-Based Cytostatics Used in Oncology with Respect to Environmental Fate and Innovative Removal Strategies of Their Metabolites. [PDF]

Molecules
Olchowski R, Morlo K, Dobrowolski R.
europepmc   +1 more source

Clinicopathological and molecular characteristics associated with pathological complete response in neoadjuvant immunotherapy for breast cancer. [PDF]

Front Immunol
Zhang B, Chen Z, Mao R, Zhu J, Cai W, Zhao B.   +5 more
europepmc   +1 more source

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.

BMJ
Liu Y, Gong Y, Zhu XZ, Liu GY, Yu KD, Yang F, Chen L, He M, Hu Z, Chen CM, Cao AY, Li JJ, Hou YF, Di GH, Wu J, Jiang YZ, Fan L, Wang ZH, Shao ZM.   +18 more
europepmc   +1 more source